It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Doctors should stop prescribing two standard antiviral drugs to treat or prevent this season's influenza because the predominant strain has quickly become resistant to them, federal health officials said Saturday.
The standard drugs are amantadine and rimantadine.
Instead, the Centers for Disease Control and Prevention recommended that doctors prescribe two newer antiviral drugs, oseltamivir (Tamiflu) and zanamivir (Relenza), and said ample supplies were available. The agency also urged the public to get flu shots.
CDC Recommends against the Use of Amantadine and Rimandatine for the Treatment or Prophylaxis of Influenza in the United States during the 2005–06 Influenza Season